Prognostic Significance of the Proximal Margin for Esophagogastric Junction Adenocarcinoma With Type II and III Tumors After Surgery

作者
Qian Yan,Weixian Hu,Jiabin Zheng,Zejian Lv,Junjiang Wang,Yong Li
出处
期刊:Research Square
标识
DOI:10.21203/rs.3.rs-121091/v1
摘要

Abstract BackgroundThe incidence of esophagogastric junction adenocarcinoma (EJA) has increased in recent years, with surgical resection the main choice of treatment. The optimal length of the proximal margin for EJA is still under debate, and the impact of EJA survival and recurrence remains unclear. The aim of the present study was to investigate the influence of the optimal length of the proximal margin on EJA.MethodsFrom January 2011 to December 2015, 131 patients who had EJA with type II tumors were included and retrospectively analyzed. All patients underwent radical R0 resection. The proximal margin was measured promptly after resection, and the frozen-section pathological examination was negative for the margin.ResultsThere were 3 cases of Siewert type I EJA (2.9 %), 75 cases of Siewert type II EJA (57.9 %), and 53 cases (40.1%) of Siewert type III EJA. The median number of lymph nodes examined was 19 (range: 1–41), and the median number of positive lymph nodes was 2 (range: 0–18). Sixty-three patients underwent total gastrectomy (48.1%), and 68 underwent proximal gastrectomy (51.9%). The median follow-up time was 57.3 months: (range 1.9–174.1); 34 patients (26%) relapsed and 74 (56.5%) died. The 5-year overall survival rate of type II tumor patients was 68.2%, and that of type III tumor patients was 38.5% (P = 0.02). For patients with a proximal margin <2 cm, the median recurrence time was 41.6 months, whereas it was for 42.8 months for patients with proximal margin >2 cm (log–rank: 0.496). Our data analysis found that a proximal margin length of 2 cm was a prognostic variable for type II and type III tumors.ConclusionsThere are a number of factors associated with recurrence and overall survival at 5 years for patients who have EJA with type II and type III tumors, and a proximal margin >2 cm may indicate better prognosis.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
科研通AI6.4的应助被DW采纳,获得10
1秒前
科研通AI6.4的应助被creat采纳,获得10
3秒前
Orange的应助被AccompanyX采纳,获得10
3秒前
3秒前
科研通AI6.4的应助被kediy采纳,获得10
4秒前
5秒前
科目三的应助被123采纳,获得10
5秒前
5秒前
田様的应助被梦于行采纳,获得10
5秒前
6秒前
6秒前
7秒前
戴苏完成签到,获得积分10
7秒前
戴苏完成签到,获得积分10
7秒前
7秒前
7秒前
8秒前
春不晚发布了新的文献求助10
8秒前
慕青的应助被霍则风采纳,获得20
8秒前
长孙曼香完成签到,获得积分10
9秒前
9秒前
9秒前
Hello的应助被欧阳辞采纳,获得10
10秒前
10秒前
Hello的应助被huyiyi采纳,获得10
11秒前
flysky120发布了新的文献求助10
11秒前
12秒前
chen9u0发布了新的文献求助10
12秒前
小狮子发布了新的文献求助10
12秒前
任性灵槐发布了新的文献求助10
12秒前
13秒前
13秒前
molihuakai的应助被卢本伟采纳,获得10
13秒前
childe发布了新的文献求助10
13秒前
乐观谷芹完成签到,获得积分10
13秒前
负责代珊发布了新的文献求助10
13秒前
13秒前
王铁柱完成签到,获得积分10
13秒前
打打的应助被俊逸依柔采纳,获得30
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Energie-Contracting 1500
Klimaschutzrecht durch den Energiesektor im Mehrebenensystem – Ein Rechtsvergleich 1000
Oncology Clinical Trials: Successful Design, Conduct, and Analysis, Second Edition 800
Stochastic Models in Operations Research,Vol. 2 600
Organizational Behavior 510
Comprehensive Heterocyclic Chemistry IV 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8047893
求助须知:如何正确求助?哪些是违规求助? 9477659
关于积分的说明 21290274
捐赠科研通 7613969
什么是DOI,文献DOI怎么找? 3392597
关于科研通互助平台的介绍 2523872
邀请新用户注册赠送积分活动 2430690